cordblood banking

Saturday, September 04, 2010

Archive for January, 2010

In weighing the pros and cons of Banking Cord Blood

Umbilical cord blood banking is another option for parents who are expecting a baby needs to be done before the birth of her baby. It is an important decision that should not be taken lightly. The final decision to bank cord blood stem cells or not is a personal decision as to what is considered appropriate for that particular family, but to make the prudent decision is to educate yourself on what to collect cord blood, weight and the pros and cons.

The banks umbilical cord blood is simply the storage or preservation of stem cells. To obtain these stem cells, your doctor may draw blood from the umbilical cord when your baby arrives. This blood is sent to the company that will have previously chosen by the services. There, stem cells are extracted from the blood and preserved specifically for use in your family's future.

Why would anyone opt for cord blood storage? Well, research is being carried out continuously and blood cells taken from this has already been used to treat and cure injuries and illnesses. Examples of cases where cord blood stem cells have been used successfully are the treatments for leukemia, lymphoma, brain injuries, brain tumors and other cancers. This is a small list, because there are about 70 diseases in which stem cells have been used for treatment. Potential applications are complete strangers as the list of successful treatments is growing.

Given the good prospects, the next question that naturally comes to mind is "Why would someone choose not to participate in the banks of cord blood stem cells?"

That's a difficult question to answer because every individual has to take into account their specific circumstances and beliefs. With the main option for saving cord blood is the cost. Another consideration is their personal beliefs and whether the use of stem cells is part of what an individual personally think is acceptable.

The average initial cost of registration for the range of renowned companies from $ 1600 to $ 2100. This price includes the kit to use for collecting, shipping charges for transporting the blood into the company's facilities, services, processing of cord blood and the extraction of stem cells, and rates of first-year storage. There are also annual maintenance fees usually average $ 125.

All parents who are expecting a baby needs to make an informed decision about what is right for them. The costs and the benefits it can offer in the future health of your family are just a couple of things to take into account in a decision.

Technorati Tags: , , , , , , , , , , , , , , , , , , , , , , ,

My local Birmingham Florist is Great

At this time of year there always seems to be so many bugs going around, that it’s inevitable you are going to catch something. It’s so much worse if you have children still at school. They always seem to be catching some sort of sniffle or cough and of course they bring it home to share with the rest of the family! Read more: My local Birmingham Florist is Great

Technorati Tags: , , , , , , , , , , , , , , , , , , , , , ,

Benefits of Cord Blood Banking

If you are pregnant, you have probably received information on the banks of umbilical cord blood. This is an opportunity for banks umbilical cord blood of her son. When banked cord blood, which is stored so that at a later time, which can be used when necessary. There are several key reasons why anyone should consider cord blood banking cord.

Cord blood contains very important cells that can help grow a healthy immune system for someone who has fallen ill. This not only can be used cord blood for your child, but for others who have the same blood type and tissue. Although cord blood banking is expensive when done in private, you can save your life and this is often the reason to consider it.

Stem cells from umbilical cord blood can be used to treat diseases and conditions such as leukemia, myelodysplastic syndrome, anemia, sickle cell disease, the inherited abnormality of red blood cells, lymphoma, plasma cell disorder, neuroblastoma and myeloma. Today, there are over 75 different diseases, immune deficiencies and other conditions that are treated with cord blood successfully. With the advancement of stem cell research is not likely to be more uses for cord blood in the future.

If a family medical history or your child has a predisposition to any of these conditions, you should seriously consider banks umbilical cord blood. Parents of children of ethnic or racial minorities and children conceived by in vitro fetilization are encouraged cord blood banks because it is more difficult to find bone marrow match in these cases. Only 50% of people who need a bone marrow transplant or stem cell is likely to find a suitable donor to provide it.

There are two ways to store umbilical cord blood of their baby. If you choose public banking of umbilical cord blood, the blood of her baby is taken from the umbilical cord, cryogenically stored and can be used by anyone who is in need of it. However, cord blood is stored in a private bank can only be used for your child or other family members when necessary.

The process of collecting cord blood can be costly for a private storage facility, from $ 2000, but the protection it offers far outweighs the costs. In addition, many families find that this is an ideal way to protect children and other family life-threatening diseases or conditions. The current stem cell research to treat diseases is promising. Stem cells from umbilical cord blood have a great potential for treating degenerative autoimmune diseases and more. Cord blood banks can provide health insurance for their child or family members now and in the future.

There are still cord blood donations taking place is not sufficient to provide for the necessary assistance needed to cure diseases like cancer and leukemia. However, with more people considering cord blood bank, whether private or public, is more probable that miracles can happen. Through better education, more parents see the true benefits of cord blood banks.

Copyright 2006 Alvin Toh

Technorati Tags: , , , , , , , , , , , , , , , , , , , , , , ,

Homemade teeth whitening – Does homemade teeth whitening mixtures save bucks

With all of the down turn around the world, folk try and find various means to save their wallet, yet consider that maintaining a pleasant appearance, also is critical. Balance between these 2 can be simply maintained, if you turn towards the homemade teeth whitening products.

Simply to get off the ugly patches found on the teeth, you need not pinch your pockets ; rather, employ straightforward homemade teeth whitening solutions. Read more: Homemade teeth whitening – Does homemade teeth whitening mixtures save bucks

Technorati Tags: , , , , , , , , , , , , , , , , , , , ,

Bay Area biotech companies are in the spot light of stem cell therapy

geronBay area companies are one step ahead in the exploding field of stem cell research. The counties of San Francisco, San Mateo and San Diego, along with the cities of Boston and Madison, Wis., have become major hubs of the nations fast-growing biotechnology sector, which includes companies working on stem cells and other areas of regenerative medicine.

Biotech giant Geron Corp. is already famous in the global race of stem cell therapy. It will be the first to begin a human clinical trial using the controversial embryonic stem cells. Geron is now all ready with federal approval for the first ever US human trial for injecting stem cells into ten paralyzed patients.

List of companies and their shares in the advancement of stem cell research

VistaGen Theraputics Inc.
City: South San Francisco
Developing: Embryonic stem cell therapies
In Oct of last year announced the signing of a strategic research agreement with Sanwa Kagaku Kenkyusho Co. Ltd. (”Sanwa”), an international pharmaceutical company
headquartered in Nagoya, Japan. Under the new agreement, VistaGen will apply
its embryonic stem cell technology portfolio to develop customized stem
cell-based discovery tools for Sanwa. Sanwa will then use the new discovery
tools to screen its compound libraries for new drug candidates for treatment
of both Type 1 and Type 2 diabetes.

ExelIxis Inc.
City: South San Francisco
Developing: Treatments for cancer
Exellxis identified the activity of XL139 a small molecule inhibitor of the hedgehog signaling pathway. Hedgehog plays a critical role in regulating cell growth, proliferation and differentiation in normal development.
The pathway is deregulated in basal cell carcinoma, medulloblastoma, glioblastoma, multiple myeloma and pancreatic and a variety of other cancers.

Inappropriate activation of hedgehog can result from activating mutations, loss of repressors or overexpression of factors that stimulate the pathway. Signaling through hedgehog also has been shown to stimulate production of angiogenic and survival factors, both in tumor cells and in the surrounding stromal tissue. In addition, recent data suggest that hedgehog signaling may play a key role in cancer stem cell (CSC) proliferation and the resistance of CSCs to chemotherapeutics and radiotherapy. preclinical data suggest that XL139 profoundly inhibits hedgehog signaling .

iZumi Bio
City: South San Francisco
Developing: Technologies to turn ordinary cells, such as skin cells, into patient-specific stem cells

Izumi Bio and Kyoto University’s Center for iPS Cell Research and Application will collaborate on research, development, and applications of induced pluripotent stem cell technology to advance drug discovery and cell-based therapies for patients.

Both the organizations’ researchers will share some cell lines. iZumi and CiRA both offer the capability to take skin cells from a diseased patient with known genotypic and phenotypic information and reprogram them to behave similarly to human embryonic stem cells. The parties will conduct comparison and characterization studies independently but will share the best methods to produce appropriate cell lines for drug screening and development as well as those best suited for cell-based therapy.

Cellerant Therapeutics Inc.
City: San Carlos
Developing: Products to regulate the blood-forming system

Cellerant Therapeutics, Inc., a biotechnology company, engages in developing hematopoietic stem cell based cellular and antibody therapies for blood disorders and cancer. Its products include CLT-001, a hematopoietic stem cell for the treatment of cancer and sickle cell diseases; and CLT-008, a cell-based medicine for treating neutropenia due to chemotherapy or radiation exposure and acute radiation syndrome.

Geron Corp.
City: Menlo Park
Developing: Embryonic stem cell therapies

Geron Corp (GERN), a biotechnology company based in Menlo, CA, is developing first-in-class biopharmaceuticals for the treatment of cancer and chronic degenerative diseases, including spinal cord injury, heart failure and diabetes.

They are advancing an anti-cancer drug and a cancer vaccine that target the enzyme telomerase through multiple clinical trials. We are also the world leader in the development of human embryonic stem cell-based therapeutics.

Geron have received FDA clearance to begin the world’s first human clinical trial of a hESC-based therapy: GRNOPC1 for acute spinal cord injury.

Stem Cells Inc.
City: Palo Alto
Developing: Neural stem cell technologies using adult brain tissue

StemCells, Inc. is focused on the discovery and development of stem cell therapeutics to treat damage to or degeneration of major organ systems such as the Central Nervous System, Liver and Pancreas.

They claimed to be a world leader in the discovery and development of human neural stem cell technology using cells derived from adult (i.e. non-embryonic) brain tissue.

They use a proprietary process to isolate, purify and expand rare candidate stem cells found in adult human tissue.

To date, we have discovered the human neural stem cell as well as a population of rare candidate stem cells found in human liver and pancreas.

SanBio Inc.
City: Mountain View
Developing: Therapies based on stem cells and other regenerative medicines for neurological disorders.

SanBio has pioneered and is the leader in the development of technology to convert donor bone marrow cells to various types of cells for use in regenerative medicine. The Company’s first products are in the later stages of preclinical development using SanBio’s proprietary technology to create cells for use in the treatment of neurological disorders.

SanBio has an expanding portfolio of products. SanBio has used its proprietary technology to develop three products, SB623 for the treatment of stroke, spinal cord injury, and Parkinsons disease, SB618 for the treatment of multiple sclerosis and spinal cord injury, and SB308 for the treatment of muscular dystrophy and trauma.

SanBio is also exploring the opportunity to deploy its technology to produce other types of cells to address unmet medical needs. In principle, the Company believes its technology can be used to treat any degenerative disease in which the recovery or replacement of functioning cells or tissues could provide long term benefit.

Source: .thescizone.com

Filed under Adult Stem Cell, Americas, Brain Disease, Cancer, Diabetes, Embryonic Stem Cell, Eye, Heart, Leukemia, Liver, Spinal Cord Injury, Stem Cell, induced pluripotent stem cell, sickle cell disease, skin | Comment Below

Technorati Tags: , , , , , , , , , , , , , , , , , , ,

SEO Powered by Platinum SEO from Techblissonline